FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2326578176> ?p ?o ?g. }

• W2326578176 abstract "Mammalian cells fuel their growth and proliferation through the catabolism of two main substrates: glucose and glutamine. Both nutrients are required for the synthesis of glucosamine, the precursor substrate of the hexosamine biosynthetic pathway. The hexosamine signaling pathway terminating in O-linked N-acetyl glucosamine (O-GlcNAc) cycling has been implicated in cellular signaling cascades and regulation of transcription factors involved in cancer biology. Biological functions of the hexosamine biosynthetic signaling pathways need elucidation, to determine whether altered O-GlcNAc metabolism plays a significant role in hematologic tumors such as diffuse large B-cell lymphoma (DLBCL), and utilize this bifunctional pathway as a targeted therapeutic strategy in DLBCL. We have identified a key enzyme of the hexosamine biosynthetic pathways to be highly-expressed in DLBCL cell lines and patient tumor cells. In contrast to normal circulating and tonsillar B cells, DLBCL cells expressed high levels of the terminating enzyme O-GlcNAc transferase (OGT). OGT mRNA expression is highly expressed in DLBCL in comparaison to other cancers. We discovered that several key growth and survival transcription factors, such as NF-kB and NFAT, known to be highly-activated in DLBCL, are linked to the hexoasmine biosynthetic pathway. We demonstrated that both NF-kB (p65) and NFATc1 directly associated with OGT, and down-regulation of OGT by siRNA inhibits these transcription factors activation, suggesting that both NF-kB-p65 and NFATc1 require O-GlcNAc glycosylation by OGT for their activation. These results suggest that the hexosamine pathway is highly active and utilized in DLBCL, and that exploiting this bi-functional pathway(s) as a therapeutic approach is feasible. We have previously developed an imaging agent, 99mTc-ethylenedicysteine-glucosamine (99mTc-EC-G) because EC-G mimics phosphorylated N-acetylglucosamine. ECG treatment in DLBCL cells enhances p65 and NFATc1 nuclear translocation. For therapeutic strategies, we developed metallic unlabeled Platinum (Pt) derivatives-EC-G as potential therapeutic agents. Pre-clinical in vitro studies have shown that our two lead compounds, Pt-9 and Pt-DACH-EC-G effectively inhibit lymphoma cell growth and induce apoptosis. These lead compounds can also induce DNA damage in DLBCL cells, through the up-regulation of phosphorylated histone 2AX (pH2AX), leading to the disruption of p65 and NFATc1 binding to DNA. This data importantly demonstrates that the hexosamine biosynthetic pathway is linked to key growth and survival pathways involved in the pathophysiology of DLBCL. Targeting these pathways with novel platinum EC-G compounds as a theranostic approach should lead to new, more effective treatments and diagnosis for DLBCL, particularly for relapsed/refractory DLBCL. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 218. doi:1538-7445.AM2012-218" @default.
• W2326578176 created "2016-06-24" @default.
• W2326578176 creator A5003652145 @default.
• W2326578176 creator A5013784465 @default.
• W2326578176 creator A5034933670 @default.
• W2326578176 creator A5041570474 @default.
• W2326578176 creator A5041976538 @default.
• W2326578176 creator A5053371461 @default.
• W2326578176 creator A5054939366 @default.
• W2326578176 creator A5058183790 @default.
• W2326578176 creator A5085678821 @default.
• W2326578176 date "2012-04-15" @default.
• W2326578176 modified "2023-09-24" @default.
• W2326578176 title "Abstract 218: The hexosamine biosyntheic pathway and O-linked glycosylation for targeted therapy in diffuse large B-cell lymphoma" @default.
• W2326578176 doi "https://doi.org/10.1158/1538-7445.am2012-218" @default.
• W2326578176 hasPublicationYear "2012" @default.
• W2326578176 type Work @default.
• W2326578176 sameAs 2326578176 @default.
• W2326578176 citedByCount "0" @default.
• W2326578176 crossrefType "proceedings-article" @default.
• W2326578176 hasAuthorship W2326578176A5003652145 @default.
• W2326578176 hasAuthorship W2326578176A5013784465 @default.
• W2326578176 hasAuthorship W2326578176A5034933670 @default.
• W2326578176 hasAuthorship W2326578176A5041570474 @default.
• W2326578176 hasAuthorship W2326578176A5041976538 @default.
• W2326578176 hasAuthorship W2326578176A5053371461 @default.
• W2326578176 hasAuthorship W2326578176A5054939366 @default.
• W2326578176 hasAuthorship W2326578176A5058183790 @default.
• W2326578176 hasAuthorship W2326578176A5085678821 @default.
• W2326578176 hasConcept C104317684 @default.
• W2326578176 hasConcept C181199279 @default.
• W2326578176 hasConcept C185592680 @default.
• W2326578176 hasConcept C189938988 @default.
• W2326578176 hasConcept C2776309477 @default.
• W2326578176 hasConcept C2777313579 @default.
• W2326578176 hasConcept C2779349466 @default.
• W2326578176 hasConcept C502942594 @default.
• W2326578176 hasConcept C515207424 @default.
• W2326578176 hasConcept C55493867 @default.
• W2326578176 hasConcept C62112901 @default.
• W2326578176 hasConcept C62478195 @default.
• W2326578176 hasConcept C86339819 @default.
• W2326578176 hasConcept C86803240 @default.
• W2326578176 hasConcept C95444343 @default.
• W2326578176 hasConceptScore W2326578176C104317684 @default.
• W2326578176 hasConceptScore W2326578176C181199279 @default.
• W2326578176 hasConceptScore W2326578176C185592680 @default.
• W2326578176 hasConceptScore W2326578176C189938988 @default.
• W2326578176 hasConceptScore W2326578176C2776309477 @default.
• W2326578176 hasConceptScore W2326578176C2777313579 @default.
• W2326578176 hasConceptScore W2326578176C2779349466 @default.
• W2326578176 hasConceptScore W2326578176C502942594 @default.
• W2326578176 hasConceptScore W2326578176C515207424 @default.
• W2326578176 hasConceptScore W2326578176C55493867 @default.
• W2326578176 hasConceptScore W2326578176C62112901 @default.
• W2326578176 hasConceptScore W2326578176C62478195 @default.
• W2326578176 hasConceptScore W2326578176C86339819 @default.
• W2326578176 hasConceptScore W2326578176C86803240 @default.
• W2326578176 hasConceptScore W2326578176C95444343 @default.
• W2326578176 hasLocation W23265781761 @default.
• W2326578176 hasOpenAccess W2326578176 @default.
• W2326578176 hasPrimaryLocation W23265781761 @default.
• W2326578176 hasRelatedWork W167184500 @default.
• W2326578176 hasRelatedWork W1956798807 @default.
• W2326578176 hasRelatedWork W1986247091 @default.
• W2326578176 hasRelatedWork W2040170958 @default.
• W2326578176 hasRelatedWork W2061621597 @default.
• W2326578176 hasRelatedWork W2124031707 @default.
• W2326578176 hasRelatedWork W2141412293 @default.
• W2326578176 hasRelatedWork W2155250525 @default.
• W2326578176 hasRelatedWork W2203297388 @default.
• W2326578176 hasRelatedWork W2258304092 @default.
• W2326578176 hasRelatedWork W2468773158 @default.
• W2326578176 hasRelatedWork W2476698801 @default.
• W2326578176 hasRelatedWork W2576928918 @default.
• W2326578176 hasRelatedWork W2736260042 @default.
• W2326578176 hasRelatedWork W2791738263 @default.
• W2326578176 hasRelatedWork W2886117058 @default.
• W2326578176 hasRelatedWork W2898939475 @default.
• W2326578176 hasRelatedWork W2979853451 @default.
• W2326578176 hasRelatedWork W3083235002 @default.
• W2326578176 hasRelatedWork W3163054834 @default.
• W2326578176 isParatext "false" @default.
• W2326578176 isRetracted "false" @default.
• W2326578176 magId "2326578176" @default.
• W2326578176 workType "article" @default.